The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 340:101-107 January 14, 1999 Number 2
NextNext

Calcium Supplements for the Prevention of Colorectal Adenomas
J.A. Baron, M.D., M. Beach, M.D., Ph.D., J.S. Mandel, Ph.D., R.U. van Stolk, M.D., R.W. Haile, Dr.P.H., R.S. Sandler, M.D., M.P.H., R. Rothstein, M.D., R.W. Summers, M.D., D.C. Snover, M.D., G.J. Beck, Ph.D., J.H. Bond, M.D., E.R. Greenberg, M.D., H. Frankl, M.D., L. Pearson, M.Phil., for The Calcium Polyp Prevention Study Group

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background and Methods Laboratory, clinical, and epidemiologic evidence suggests that calcium may help prevent colorectal adenomas. We conducted a randomized, double-blind trial of the effect of supplementation with calcium carbonate on the recurrence of colorectal adenomas. We randomly assigned 930 subjects (mean age, 61 years; 72 percent men) with a recent history of colorectal adenomas to receive either calcium carbonate (3 g [1200 mg of elemental calcium] daily) or placebo, with follow-up colonoscopies one and four years after the qualifying examination. The primary end point was the proportion of subjects in whom at least one adenoma was detected after the first follow-up endoscopy but up to (and including) the second follow-up examination. Risk ratios for the recurrence of adenomas were adjusted for age, sex, lifetime number of adenomas before the study, clinical center, and length of the surveillance period.

Results The subjects in the calcium group had a lower risk of recurrent adenomas. Among the 913 subjects who underwent at least one study colonoscopy, the adjusted risk ratio for any recurrence of adenoma with calcium as compared with placebo was 0.85 (95 percent confidence interval, 0.74 to 0.98; P=0.03). The main analysis was based on the 832 subjects (409 in the calcium group and 423 in the placebo group) who completed both follow-up examinations. At least one adenoma was diagnosed between the first and second follow-up endoscopies in 127 subjects in the calcium group (31 percent) and 159 subjects in the placebo group (38 percent); the adjusted risk ratio was 0.81 (95 percent confidence interval, 0.67 to 0.99; P=0.04). The adjusted ratio of the average number of adenomas in the calcium group to that in the placebo group was 0.76 (95 percent confidence interval, 0.60 to 0.96; P=0.02). The effect of calcium was independent of initial dietary fat and calcium intake.

Conclusions Calcium supplementation is associated with a significant — though moderate — reduction in the risk of recurrent colorectal adenomas.


Source Information

From the Departments of Medicine (J.A.B., R.R.), Community and Family Medicine (J.A.B.), and Anesthesia (M.B.) and the Norris Cotton Cancer Center (E.R.G.), Dartmouth–Hitchcock Medical Center, Lebanon, N.H.; the Veterans Affairs Medical Center, White River Junction, Vt. (M.B.); the Department of Environmental and Occupational Health, School of Public Health and School of Medicine (J.S.M.), and the Departments of Pathology (D.C.S.) and Medicine (J.H.B.), School of Medicine, University of Minnesota, and the Veterans Affairs Medical Center (J.H.B.), Minneapolis; the Center for Colon Polyps and Colon Cancer, Department of Gastroenterology (R.U.S.), and the Department of Biostatistics and Epidemiology (G.J.B.), Cleveland Clinic Foundation, Cleveland; the Department of Preventive Medicine, University of Southern California School of Medicine, Los Angeles (R.W.H.); the Department of Medicine, University of North Carolina, Chapel Hill, N.C. (R.S.S.); the James A. Clifton Center for Digestive Diseases, Department of Internal Medicine, University of Iowa College of Medicine, Iowa City (R.W.S.); and the Department of Pathology, Fairview Southdale Hospital, Minneapolis (D.C.S.). Other authors were H. Frankl, M.D., Department of Internal Medicine, Southern California Permanente Group, Los Angeles; and L. Pearson, M.Phil., Department of Community and Family Medicine, Dartmouth–Hitchcock Medical Center, Lebanon, N.H.

Address reprint requests to Dr. Baron at 7927 Rubin Bldg., Dartmouth–Hitchcock Medical Center, 1 Medical Center Dr., Lebanon, NH 03756.

Full Text of this Article


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.